ClinConnect ClinConnect Logo
Search / Trial NCT05563090

Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools

Launched by SINGAPORE CHUNG HWA MEDICAL INSTITUTION · Sep 28, 2022

Trial Information

Current as of May 18, 2025

Completed

Keywords

Diabetes Mellitus Type Ii Diabetes Pre Diabetes Healthy Subjects Hypertension Dyslipidemia Tcm Tcm Diagnosis Pulse Diagnosis Tongue Diagnosis

ClinConnect Summary

This clinical trial is studying how to better understand the different types of conditions related to diabetes and pre-diabetes using Traditional Chinese Medicine (TCM) techniques combined with modern technology. The goal is to improve how we identify and treat these conditions among patients in Singapore, which may help in preventing diabetes and tailoring treatments to meet the specific needs of the local population.

To participate, individuals aged 21 to 75 who have been diagnosed with type II diabetes, prediabetes, or who are healthy without any chronic conditions are eligible. Participants will undergo a thorough evaluation during a single visit, which includes health assessments and questionnaires about their lifestyle and diet. The trial is currently recruiting, and the findings may provide valuable insights into more effective treatment options for diabetes and prediabetes in Singapore.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 21-75 years old, inclusive;
  • * Clinically diagnosed with one of the following:
  • 1. Type II Diabetes Mellitus with or without hypertension and dyslipidemia
  • 2. Prediabetes with or without hypertension and dyslipidemia
  • 3. Healthy or sub-healthy subject without clinically diagnosed chronic conditions such as diabetes, hypertension or dyslipidemia
  • Exclusion Criteria:
  • Subjects diagnosed with Gestational Diabetes
  • Subjects who are pregnant or lactating
  • Subjects with chronic heart failure, history of carcinomas with treatment of chemotherapy/radiotherapy, psychological, or psychiatric disorders
  • Subjects with heart diseases and transplanted devices such as pacemakers;
  • Subjects with acute infections such as upper respiratory infections, acute gastroenteritis, or urinary tract infections;
  • Subjects unable to undergo evaluation with the pulse sphygmograph, tongue detection or complete the questionnaire;
  • Subjects with communication disorders
  • Subjects with gastroenterology diseases or are diagnosed with 'spleen and stomach deficiency' (脾胃虚弱)
  • Subjects undergoing TCM treatment for diabetes or pre-diabetes within 1 week

About Singapore Chung Hwa Medical Institution

Singapore Chung Hwa Medical Institution is a leading healthcare organization dedicated to advancing medical research and patient care through innovative clinical trials. With a commitment to improving health outcomes, the institution collaborates with a network of healthcare professionals and researchers to facilitate the development of new therapies and medical interventions. By prioritizing patient safety and ethical standards, Singapore Chung Hwa Medical Institution plays a pivotal role in the clinical research landscape, contributing to the advancement of medical knowledge and enhancing the quality of life for diverse patient populations.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials